In conclusion, although deeper analyses and alternative approaches targeting mitophagy are warranted, the current dataset suggests that selectively and partially blocking BNIP3 overexpression to prevent excessive mitochondrial disposal represents a promising therapeutic goal for counteracting muscle wasting in cancer patients. This evidence concerns the gene BNIP3 and cancer.